1-3 of 3
Darren Pan
Close
Sort by
Journal Articles

Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H. Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua A. Fein, Jorge Monge, Cara Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Mapara, Giorgio Inghirami, Suzanne Lentzsch, Ran Reshef, Adriana Rossi, Samir Parekh, Sundar Jagannath, Shambavi Richard, Ruben Niesvizky, Mark Bustoros
Journal: Blood Advances
Blood Adv (2024) 8 (15): 3859–3869.
https://doi.org/10.1182/bloodadvances.2023012470
Published: 2024
Includes: Supplemental data
Journal Articles

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Tarek H. Mouhieddine, Oliver Van Oekelen, David T. Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1056–1064.
https://doi.org/10.1182/bloodadvances.2022007923
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical developments in epigenetic-directed therapies in acute myeloid leukemia

Darren Pan, Raajit Rampal, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (5): 970–982.
https://doi.org/10.1182/bloodadvances.2019001245
Published: 2020